Vossel Lab
Our Research
The Vossel Laboratory studies mechanisms and novel treatments for epileptic activity and associated memory loss in Alzheimer’s disease. Investigations include cell and molecular, neural network, and behavior relationships in mouse models of Alzheimer’s disease and related dementias, and bridges bench discoveries with human clinical trials.
Recent Media Coverage
June 17, 2024: Dr. Keith Vossel was interviewed by Los Angeles Times for article, “New drug’s potentially fatal side effects obscured by ‘soothing acronym,’ doctors say.” Read the Los Angeles Times article
June 14, 2024: Dr. Keith Vossel was interviewed by Marla Tellez on Fox 11 Los Angeles about FDA advisory panels recommendation for the Alzheimers drug donanemab. Watch the Fox LA Interview
June 12, 2024: Dr. Keith Vossel, Professor of Neurology at UCLA was interviewed by KNX-AM(Radio) about Alzheimer's drug Leqembi. Listen to the KNX-AM(Radio) Interview